476 related articles for article (PubMed ID: 9441825)
1. A 5' dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy.
Bies RD; Maeda M; Roberds SL; Holder E; Bohlmeyer T; Young JB; Campbell KP
J Mol Cell Cardiol; 1997 Dec; 29(12):3175-88. PubMed ID: 9441825
[TBL] [Abstract][Full Text] [Related]
2. Interactions between dystrophin and the sarcolemma membrane.
Chamberlain JS; Corrado K; Rafael JA; Cox GA; Hauser M; Lumeng C
Soc Gen Physiol Ser; 1997; 52():19-29. PubMed ID: 9210217
[TBL] [Abstract][Full Text] [Related]
3. Dystroglycan mRNA expression during normal and mdx mouse embryogenesis: a comparison with utrophin and the apo-dystrophins.
Schofield JN; Górecki DC; Blake DJ; Davies K; Edwards YH
Dev Dyn; 1995 Oct; 204(2):178-85. PubMed ID: 8589441
[TBL] [Abstract][Full Text] [Related]
4. Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers.
Ohlendieck K
Eur J Cell Biol; 1996 Jan; 69(1):1-10. PubMed ID: 8825019
[TBL] [Abstract][Full Text] [Related]
5. Differential distribution of the members of the dystrophin glycoprotein complex in mouse retina: effect of the mdx(3Cv) mutation.
Dalloz C; Claudepierre T; Rodius F; Mornet D; Sahel J; Rendon A
Mol Cell Neurosci; 2001 May; 17(5):908-20. PubMed ID: 11358487
[TBL] [Abstract][Full Text] [Related]
6. Sarcoglycans in muscular dystrophy.
Hack AA; Groh ME; McNally EM
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
[TBL] [Abstract][Full Text] [Related]
7. WW and EF hand domains of dystrophin-family proteins mediate dystroglycan binding.
Chung W; Campanelli JT
Mol Cell Biol Res Commun; 1999; 2(3):162-71. PubMed ID: 10662592
[TBL] [Abstract][Full Text] [Related]
8. Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy.
Franz WM; Müller M; Müller OJ; Herrmann R; Rothmann T; Cremer M; Cohn RD; Voit T; Katus HA
Lancet; 2000 May; 355(9217):1781-5. PubMed ID: 10832829
[TBL] [Abstract][Full Text] [Related]
9. Localization of the dystrophin binding site at the carboxyl terminus of beta-dystroglycan.
Rosa G; Ceccarini M; Cavaldesi M; Zini M; Petrucci TC
Biochem Biophys Res Commun; 1996 Jun; 223(2):272-7. PubMed ID: 8670271
[TBL] [Abstract][Full Text] [Related]
10. Dystroglycan expression in the wild type and mdx mouse neural retina: synaptic colocalization with dystrophin, dystrophin-related protein but not laminin.
Montanaro F; Carbonetto S; Campbell KP; Lindenbaum M
J Neurosci Res; 1995 Nov; 42(4):528-38. PubMed ID: 8568939
[TBL] [Abstract][Full Text] [Related]
11. Utrophin-dystroglycan complex in membranes of adherent cultured cells.
James M; Nguyen TM; Wise CJ; Jones GE; Morris GE
Cell Motil Cytoskeleton; 1996; 33(3):163-74. PubMed ID: 8674136
[TBL] [Abstract][Full Text] [Related]
12. The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan.
Rentschler S; Linn H; Deininger K; Bedford MT; Espanel X; Sudol M
Biol Chem; 1999 Apr; 380(4):431-42. PubMed ID: 10355629
[TBL] [Abstract][Full Text] [Related]
13. Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?
Matsumura K; Saito F; Yamada H; Hase A; Sunada Y; Shimizu T
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):751-62. PubMed ID: 10541473
[TBL] [Abstract][Full Text] [Related]
14. Direct interaction of beta-dystroglycan with F-actin.
Chen YJ; Spence HJ; Cameron JM; Jess T; Ilsley JL; Winder SJ
Biochem J; 2003 Oct; 375(Pt 2):329-37. PubMed ID: 12892561
[TBL] [Abstract][Full Text] [Related]
15. [Dystrophin, dystrophin-associated protein and dystrophinopathy].
Ozawa E
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):289-93. PubMed ID: 7584723
[TBL] [Abstract][Full Text] [Related]
16. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.
Martin PT
Glycobiology; 2003 Aug; 13(8):55R-66R. PubMed ID: 12736199
[TBL] [Abstract][Full Text] [Related]
17. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
Matsumura K; Campbell KP
Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
[TBL] [Abstract][Full Text] [Related]
18. In vitro developmental expression of dystroglycan and laminin-alpha2 in human skeletal muscle.
Chen L; Burgunder JM
Cell Biol Int; 2005 Jul; 29(7):506-13. PubMed ID: 15982904
[TBL] [Abstract][Full Text] [Related]
19. The mouse dystrophin muscle enhancer-1 imparts skeletal muscle, but not cardiac muscle, expression onto the dystrophin Purkinje promoter in transgenic mice.
De Repentigny Y; Marshall P; Worton RG; Kothary R
Hum Mol Genet; 2004 Nov; 13(22):2853-62. PubMed ID: 15385445
[TBL] [Abstract][Full Text] [Related]
20. A dystrophin missense mutation showing persistence of dystrophin and dystrophin-associated proteins yet a severe phenotype.
Goldberg LR; Hausmanowa-Petrusewicz I; Fidzianska A; Duggan DJ; Steinberg LS; Hoffman EP
Ann Neurol; 1998 Dec; 44(6):971-6. PubMed ID: 9851445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
